Skip to main content
Erschienen in: Urolithiasis 3/2012

01.06.2012 | Original Paper

The impact of metaphylaxis of kidney stone disease in the renal function at long term in active kidney stone formers patients

verfasst von: Jose A. Meneses, Fernando M. Lucas, Fernando C. Assunção, Junia P. P. Castro, Rogério B. Monteiro

Erschienen in: Urolithiasis | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

A total of 150 patients were included in the analysis. Through chart review, we estimated glomerular filtration rate in the first visit and, at least, 5 years later. All patients were divided into two groups: (1) metaphylaxis adherents (n = 74) and (2) metaphylaxis non-adherents (n = 76). We followed all patients for at least 5 years. The Scr percentage of patients and GFR <60 mL/min was compared between groups. Variables were compared between groups using t test, χ2 tests, odds ratios with 95% confidence intervals. There were no differences at baseline between groups. After 5 years of follow-up, GFR was 77.9 mL/min in non-adherent-metaphylaxis group and in the adherent-metaphylaxis group was 87.3 mL/min, with p value of 0.02. After 5 years of follow-up, we had a GFR <60 mL/min in the adherent-metaphylaxis group (4.89 vs. 21.95%) with p value of 0.001 and OR = 5.36; IC-95% = 1.95–14.8. Metaphylaxis of kidney stone disease could prevent chronic kidney disease.
Literatur
2.
Zurück zum Zitat Romro V, Akpinar H, Assinos DG (2010) Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev Urol 12(2–3):e86–e96 Romro V, Akpinar H, Assinos DG (2010) Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev Urol 12(2–3):e86–e96
3.
Zurück zum Zitat Lieske JC, Peja de la Vega LS, Slezak JM, Bergstralh EJ, Leibson CL, Ho KL, Gettman MT (2006) Renal stone epidemiology in Rochester, Minnesota: an update. Kidney Int 69(4):760–764PubMedCrossRef Lieske JC, Peja de la Vega LS, Slezak JM, Bergstralh EJ, Leibson CL, Ho KL, Gettman MT (2006) Renal stone epidemiology in Rochester, Minnesota: an update. Kidney Int 69(4):760–764PubMedCrossRef
4.
Zurück zum Zitat Stamatelou KK, Francis ME, Jones CA et al (2003) Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int 63:1817–1823PubMedCrossRef Stamatelou KK, Francis ME, Jones CA et al (2003) Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int 63:1817–1823PubMedCrossRef
5.
Zurück zum Zitat Frymoyer PA, Scheinman SJ, Dunhan DB, Jones DB, Hueben P, Schoroeder ET (1991) X-linked recessive nephrolithiasis with renal failure. N Engl J Med 325(10):681–686PubMedCrossRef Frymoyer PA, Scheinman SJ, Dunhan DB, Jones DB, Hueben P, Schoroeder ET (1991) X-linked recessive nephrolithiasis with renal failure. N Engl J Med 325(10):681–686PubMedCrossRef
6.
Zurück zum Zitat Leumann EP (1985) Primary hyperoxaluria: an important cause of renal failure in infancy. Int J Pediatr Nephrol 6(1):13–16PubMed Leumann EP (1985) Primary hyperoxaluria: an important cause of renal failure in infancy. Int J Pediatr Nephrol 6(1):13–16PubMed
7.
Zurück zum Zitat De Walter R, Noordermeer C, Nizze H, Schröder FH, Kok DJ (1999) Calcium oxalate nephrolithiasis: the significance of monocytes and macrophages. In: Borghi L, Meschi T, Briganti A, Schianchi T, Novarini (eds) Kidney stones, proceedings of the European symposium on urolithiasis, Parma, Italy, editoriale bios, pp 329–333 De Walter R, Noordermeer C, Nizze H, Schröder FH, Kok DJ (1999) Calcium oxalate nephrolithiasis: the significance of monocytes and macrophages. In: Borghi L, Meschi T, Briganti A, Schianchi T, Novarini (eds) Kidney stones, proceedings of the European symposium on urolithiasis, Parma, Italy, editoriale bios, pp 329–333
8.
Zurück zum Zitat Toblli EJ, Romano L, Nyberg C, Angerosa M, Pagano P, Ferder L, Inserra F (1996) Renal tubulointersticial (TI) protection in hyperoxaluric (Hox) rats. J Am Soc Nephrol 6:1748A (abstract) Toblli EJ, Romano L, Nyberg C, Angerosa M, Pagano P, Ferder L, Inserra F (1996) Renal tubulointersticial (TI) protection in hyperoxaluric (Hox) rats. J Am Soc Nephrol 6:1748A (abstract)
9.
Zurück zum Zitat Holmes MS, Lieske JC, Pawar S, Spargo BH, Toback FG (1995) Calcium oxalate monohydrate crystals stimulate gene expression in renal epithelial cells. Kidney Int 48:501–509CrossRef Holmes MS, Lieske JC, Pawar S, Spargo BH, Toback FG (1995) Calcium oxalate monohydrate crystals stimulate gene expression in renal epithelial cells. Kidney Int 48:501–509CrossRef
10.
Zurück zum Zitat Koul H, Kennington L, Honeyman T, Jonassenn J, Menon M, Scheid C (1996) Activation of c-myc gene expression in renal epithelial cells in LLC-PK1 cell, a line of renal epithelial cells. Kidney Int 50:1525–1530PubMedCrossRef Koul H, Kennington L, Honeyman T, Jonassenn J, Menon M, Scheid C (1996) Activation of c-myc gene expression in renal epithelial cells in LLC-PK1 cell, a line of renal epithelial cells. Kidney Int 50:1525–1530PubMedCrossRef
11.
Zurück zum Zitat Lieske JC, Hammes MS, Hoyer JR, Toback G (1997) Renal cell osteopontin production is stimulated by calcium oxalate monohydrate crystals. Kidney Int 51:679–686PubMedCrossRef Lieske JC, Hammes MS, Hoyer JR, Toback G (1997) Renal cell osteopontin production is stimulated by calcium oxalate monohydrate crystals. Kidney Int 51:679–686PubMedCrossRef
12.
Zurück zum Zitat Koten JW, Van Gastel C, Dorhoutmees EJ, Holleman LWJ, Schuiling RD (1965) Two cases of primary oxalosis. J Clin Pathol 18:223–229PubMedCrossRef Koten JW, Van Gastel C, Dorhoutmees EJ, Holleman LWJ, Schuiling RD (1965) Two cases of primary oxalosis. J Clin Pathol 18:223–229PubMedCrossRef
13.
Zurück zum Zitat Lieske JC, Spargo BH, Toback G (1992) Endocytosis of calcium oxalate crystals and proliferation of renal tubular epithelial cells in a with type 1 primary hyperoxaluria. J Urol 148:1517–1519PubMed Lieske JC, Spargo BH, Toback G (1992) Endocytosis of calcium oxalate crystals and proliferation of renal tubular epithelial cells in a with type 1 primary hyperoxaluria. J Urol 148:1517–1519PubMed
14.
Zurück zum Zitat Goswami A, Singhal PC, Wagner JD, Urivetky M, Valderrama E, Smith AD (1995) Matrix modulates uptake of calcium oxalate crystals and cell growth of renal epithelial cells. J Urol 153:206–211PubMedCrossRef Goswami A, Singhal PC, Wagner JD, Urivetky M, Valderrama E, Smith AD (1995) Matrix modulates uptake of calcium oxalate crystals and cell growth of renal epithelial cells. J Urol 153:206–211PubMedCrossRef
15.
Zurück zum Zitat Lieske JC, Toback FG (1996) Interaction of urinary crystals with renal epithelial cells en the pathogenesis of nephrolithiasis. Semin Nephrol 16:458–473PubMed Lieske JC, Toback FG (1996) Interaction of urinary crystals with renal epithelial cells en the pathogenesis of nephrolithiasis. Semin Nephrol 16:458–473PubMed
16.
Zurück zum Zitat Scheid CR, Koul H, Hill WA, Luber-Narod J, Kenington L, Honeyman T, Jonassen J, Menon M (1996) Oxalate toxicity in LLC-PK1 cells: role of free radicals. Kidney Int 49:413–419PubMedCrossRef Scheid CR, Koul H, Hill WA, Luber-Narod J, Kenington L, Honeyman T, Jonassen J, Menon M (1996) Oxalate toxicity in LLC-PK1 cells: role of free radicals. Kidney Int 49:413–419PubMedCrossRef
17.
Zurück zum Zitat Hosking DH, Erickson SB, Van den Berg CJ, Wilson DM, Smith LH (1983) The stone clinic effect in patients with idiopathic calcium urolithiasis. J Urol 130(6):1115–1118PubMed Hosking DH, Erickson SB, Van den Berg CJ, Wilson DM, Smith LH (1983) The stone clinic effect in patients with idiopathic calcium urolithiasis. J Urol 130(6):1115–1118PubMed
18.
Zurück zum Zitat Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, Maggiore U, Novarini A (2002) Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 346(2):77–84PubMedCrossRef Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, Maggiore U, Novarini A (2002) Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 346(2):77–84PubMedCrossRef
19.
Zurück zum Zitat Ettinger B, Citron JT, Livermore B, Dolman LI (1988) Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not. J Urol 139(4):679–684PubMed Ettinger B, Citron JT, Livermore B, Dolman LI (1988) Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not. J Urol 139(4):679–684PubMed
20.
Zurück zum Zitat Nijenhuis T, Hoenderop JG, Loffing J, van der Kemp AW, van Os CH, Bindels RJ (2003) Thiazide-induced hypocalciuria is accompanied by a decreased expression of Ca2+ transport proteins in kidney. Kidney Int 64(2):555–564PubMedCrossRef Nijenhuis T, Hoenderop JG, Loffing J, van der Kemp AW, van Os CH, Bindels RJ (2003) Thiazide-induced hypocalciuria is accompanied by a decreased expression of Ca2+ transport proteins in kidney. Kidney Int 64(2):555–564PubMedCrossRef
21.
Zurück zum Zitat Ettinger B, Tang A, Citron JT, Livermore B, Williams T (1986) Randomized trial of allopurinol in the prevention of calcium oxalate calculi. N Engl J Med 315(22):1386–1389PubMedCrossRef Ettinger B, Tang A, Citron JT, Livermore B, Williams T (1986) Randomized trial of allopurinol in the prevention of calcium oxalate calculi. N Engl J Med 315(22):1386–1389PubMedCrossRef
22.
Zurück zum Zitat Favus MJ, Coe FL (1980) The effects of allopurinol treatment on stone formation on hyperuricosuric calcium oxalate stone-formers. Scand J Urol Nephrol Suppl 53:265–271PubMed Favus MJ, Coe FL (1980) The effects of allopurinol treatment on stone formation on hyperuricosuric calcium oxalate stone-formers. Scand J Urol Nephrol Suppl 53:265–271PubMed
23.
Zurück zum Zitat Barcelo P, Wuhl O, Servitge E, Rousaud A, Pak CY (1993) Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urol 150(6):1761–1764PubMed Barcelo P, Wuhl O, Servitge E, Rousaud A, Pak CY (1993) Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urol 150(6):1761–1764PubMed
24.
Zurück zum Zitat Coe FL, Parks JH, Asplin JR (1992) The pathogenesis and treatment of kidney stones. N Engl J Med 327(16):1141–1152PubMedCrossRef Coe FL, Parks JH, Asplin JR (1992) The pathogenesis and treatment of kidney stones. N Engl J Med 327(16):1141–1152PubMedCrossRef
25.
Zurück zum Zitat Vupputuri S, Soucie M, Mcclellan W, Sandler DP (2004) History of kidney stones as a possible factor for chronic kidney disease. AEP 14(3):222–228PubMed Vupputuri S, Soucie M, Mcclellan W, Sandler DP (2004) History of kidney stones as a possible factor for chronic kidney disease. AEP 14(3):222–228PubMed
26.
Zurück zum Zitat Jungers P, Joly D, Barbey F, Choukroun G, Daudon M (2004) ESRD caused by nephrolithiasis: prevalence, mechanisms, and prevention. Am J Kidney Dis 44(5):799–805PubMed Jungers P, Joly D, Barbey F, Choukroun G, Daudon M (2004) ESRD caused by nephrolithiasis: prevalence, mechanisms, and prevention. Am J Kidney Dis 44(5):799–805PubMed
27.
28.
Zurück zum Zitat Larssom PA, Cano M, Grenabo L, Brorson J-E, Hederlin H, Petersson S, Johansson SL (1989) Morphological lesions or rat urinary tract pathogens. Urol Int 44:210–217CrossRef Larssom PA, Cano M, Grenabo L, Brorson J-E, Hederlin H, Petersson S, Johansson SL (1989) Morphological lesions or rat urinary tract pathogens. Urol Int 44:210–217CrossRef
29.
Zurück zum Zitat Braude AI, Siemenski I (1960) Role of bacterial urease in experimental pyelonephritis. J Bacteriol 80:171–179PubMed Braude AI, Siemenski I (1960) Role of bacterial urease in experimental pyelonephritis. J Bacteriol 80:171–179PubMed
30.
Zurück zum Zitat Mac Laren DM, Peerbooms PGH (1986) Urinary infection by urea splitting microorganism. In: Asscher AW, Brumfitt W (eds) Microbial diseases in nephrology. Wiley, New York Mac Laren DM, Peerbooms PGH (1986) Urinary infection by urea splitting microorganism. In: Asscher AW, Brumfitt W (eds) Microbial diseases in nephrology. Wiley, New York
31.
Zurück zum Zitat Koga S, Arakaki Y, Matsuoka M, Ohyma C (1991) Staghorn calculi: long term results of management. Br J Urol 68:122–124PubMedCrossRef Koga S, Arakaki Y, Matsuoka M, Ohyma C (1991) Staghorn calculi: long term results of management. Br J Urol 68:122–124PubMedCrossRef
32.
Zurück zum Zitat Igarashi T, Hayakawa H, Shiraga H, Kawato H, Yan K, Kawaguchi H, Yamanaka T, Tsuchida S, Akagi K (1995) Hypercalciuria and nephrocalcinosis in patients with idiopathic low-molecular-weight proteinuria in Japan: is disease identical to Dent’s disease in United Kingdom. Nephron 69:242–247PubMedCrossRef Igarashi T, Hayakawa H, Shiraga H, Kawato H, Yan K, Kawaguchi H, Yamanaka T, Tsuchida S, Akagi K (1995) Hypercalciuria and nephrocalcinosis in patients with idiopathic low-molecular-weight proteinuria in Japan: is disease identical to Dent’s disease in United Kingdom. Nephron 69:242–247PubMedCrossRef
33.
Zurück zum Zitat Khan SR (2010) Nephrocalcinosis in animal models with and without stones. Urol Res 38(6):429–438PubMedCrossRef Khan SR (2010) Nephrocalcinosis in animal models with and without stones. Urol Res 38(6):429–438PubMedCrossRef
34.
Zurück zum Zitat Sakhaee K (2008) Nephrolithiasis as a systemic disorder. Curr Opin Nephrol Hypertens 17:304–309PubMedCrossRef Sakhaee K (2008) Nephrolithiasis as a systemic disorder. Curr Opin Nephrol Hypertens 17:304–309PubMedCrossRef
35.
Zurück zum Zitat Evan AP, Coe FL, Lingeman JE, Worcester E (2005) Insights on the pathology of kidney stone formation. Urol Res 33(5):333–389CrossRef Evan AP, Coe FL, Lingeman JE, Worcester E (2005) Insights on the pathology of kidney stone formation. Urol Res 33(5):333–389CrossRef
Metadaten
Titel
The impact of metaphylaxis of kidney stone disease in the renal function at long term in active kidney stone formers patients
verfasst von
Jose A. Meneses
Fernando M. Lucas
Fernando C. Assunção
Junia P. P. Castro
Rogério B. Monteiro
Publikationsdatum
01.06.2012
Verlag
Springer-Verlag
Erschienen in
Urolithiasis / Ausgabe 3/2012
Print ISSN: 2194-7228
Elektronische ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-011-0407-5

Weitere Artikel der Ausgabe 3/2012

Urolithiasis 3/2012 Zur Ausgabe

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.